Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...
Q4 2025 Earnings Call March 31, 2026 4:30 PM EDTCompany ParticipantsGregory Demopulos - Co-Founder, Chairman, CEO ...
Omeros, a biopharmaceutical company, marked a significant milestone in its fourth quarter of 2025 with two major successes ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
Alain Chariot's team has just published a study in EMBO Molecular Medicine shedding light on the unexpected role of the ...
Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results